Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary: North America Pharmaceutical Contract Sales Outsourcing (CSO) Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights
5.1. Healthcare Industry Overview
5.2. Impact of Sunshine Act on Contract Sales
5.3. Regulatory Scenario
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Service, 2017–2031
6.3.1. Personal Promotion
6.3.1.1. Promotional Sales Team
6.3.1.1.1. Dedicated Sales Team
6.3.1.1.2. Syndicated Sales Team
6.3.1.2. Key Account Management
6.3.1.3. Vacancy Management
6.3.2. Non-personal Promotion
6.3.2.1. Tele-detailing
6.3.2.2. Interactive E-Detailing
6.3.2.3. Customer Service
6.3.2.4. Medical Science Liaisons
6.3.2.5. Patient Engagement Services
6.3.3. Others
6.4. Market Attractiveness Analysis, by Service

7. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Therapeutic Area
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Therapeutic Area, 2017–2031
7.3.1. Cardiovascular Disorders
7.3.2. Oncology
7.3.3. Metabolic Disorders
7.3.4. Neurology
7.3.5. Orthopedic Diseases
7.3.6. Infectious Diseases
7.3.7. Others
7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Competition Landscape
8.1. Market Player - Competition Matrix (by tier and size of companies)
8.2. Market Share Analysis, by Company, 2021
8.3. Company Profiles
8.3.1. Ashfield (UDG Healthcare plc)
8.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
8.3.1.2. Company Financials
8.3.1.3. Growth Strategies
8.3.1.4. SWOT Analysis
8.3.2. Granard Pharmaceutical Sales & Marketing
8.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
8.3.2.2. Company Financials
8.3.2.3. Growth Strategies
8.3.2.4. SWOT Analysis
8.3.3. Syneos Health
8.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
8.3.3.2. Company Financials
8.3.3.3. Growth Strategies
8.3.3.4. SWOT Analysis
8.3.4. Amplity Health
8.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
8.3.4.2. Company Financials
8.3.4.3. Growth Strategies
8.3.4.4. SWOT Analysis
8.3.5. IQVIA
8.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
8.3.5.2. Company Financials
8.3.5.3. Growth Strategies
8.3.5.4. SWOT Analysis
8.3.6. EVERSANA
8.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
8.3.6.2. Company Financials
8.3.6.3. Growth Strategies
8.3.6.4. SWOT Analysis



List of Figures

List of Figures

Figure 01: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: North America Pharmaceutical Contract Sales Outsourcing[CSO] Market, by Service, 2021 and 2031

Figure 03: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Attractiveness Analysis, by Service, 2022–2031

Figure 04: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Personal Promotion, 2017–2031

Figure 05: North America Pharmaceutical Contract Sales Outsourcing [CSO] (US$ Mn), by Non-personal Promotion, 2017–2031

Figure 06: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Others, 2017–2031

Figure 07: North America Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031

Figure 08: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Attractiveness Analysis, by Therapeutic Area, 2022–2031

Figure 09: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Cardiovascular Disorders, 2017–2031

Figure 10: North America Pharmaceutical Contract Sales Outsourcing [CSO] (US$ Mn), by Oncology, 2017–2031

Figure 11: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Metabolic Disorders, 2017–2031

Figure 12: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Neurology, 2017–2031

Figure 13: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Orthopedic Diseases, 2017–2031

Figure 14: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Infectious Diseases, 2017–2031

Figure 15: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market (US$ Mn), by Others, 2017–2031

Figure 16: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, 2017–2031

Figure 17: U.S. Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021 and 2031

Figure 18: U.S. Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Service, 2022–2031

Figure 19: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Personal Promotion, 2017–2031

Figure 20: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Non-personal Promotion, 2017–2031

Figure 21: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017–2031

Figure 22: U.S. Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031

Figure 23: U.S. Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022–2031

Figure 24: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Cardiovascular Disorders, 2017–2031

Figure 25: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Oncology, 2017–2031

Figure 26: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Metabolic Disorders, 2017–2031

Figure 27: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Neurology, 2017–2031

Figure 28: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Orthopedic Diseases, 2017–2031

Figure 29: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Infectious Diseases, 2017–2031

Figure 30: U.S. Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017–2031

Figure 31: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Canada Pharmaceutical Contract Sales Outsourcing Market, by Service, 2021 and 2031

Figure 33: Canada Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Service, 2022–2031

Figure 34: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Personal Promotion, 2017–2031

Figure 35: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Non-personal Promotion, 2017–2031

Figure 36: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Others, 2017–2031

Figure 37: Canada Pharmaceutical Contract Sales Outsourcing Market, by Therapeutic Area, 2021 and 2031

Figure 38: Canada Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022–2031

Figure 39: Canada Pharmaceutical Contract Sales Outsourcing Market (US$ Mn), by Cardiovascular Disorders, 2017–2031

List of Tables

List of Tables

Table 01: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Service, 2017-2031

Table 02: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031

Table 03: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031

Table 04: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Non-Personal Promotion, 2017-2031

Table 05: North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 06: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Service, 2017-2031

Table 07: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031

Table 08: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031

Table 09: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Non-Personal Promotion, 2017-2031

Table 10: U.S. Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 11: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Service, 2017-2031

Table 12: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Personal Promotion, 2017-2031

Table 13: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Promotional Sales Team, 2017-2031

Table 14: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Non-personal Promotion, 2017-2031

Table 15: Canada Pharmaceutical Contract Sales Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031